(mean 9.27, SD 2.05; t = 0.37; P = 0.71). When the seizure durations were compared, seizure duration was longer in the propofol anesthesia group (mean 44.38, SD 14.52) than in the nonanesthesia group (mean 39.45, SD 3.47). However, this difference was not significant (t = 1.26, P = 0.22). Mean (SD) propofol dosage was 98.68 (4.48) mg. We found no linear correlation between the propofol dosage and seizure duration (r = 0.24, P = 0.41). We assessed the effect of both the number of ECTs and having anesthesia on seizure duration; no effects for ECT number (F 1,11 = 1.80, P > 0.05) or patient group (F = 0.81, P < 0.05) were revealed, nor was there any significant interaction between the number of ECTs and the patient group (F 1,11 = 1.55, P < 0.05).
Discussion
Contrary to previous studies (6-8), we did not find that propofol had any considerable effect on seizure duration. Our study design was different from other studies in that they compared 2 different induction agents (9) (10) (11) ; in our study, seizure durations of patients who received propofol anesthesia were compared with seizure durations of patients who received ECT treatments without anesthesia. Current standards, especially for research purposes, would preclude the use of ECT without anesthesia, but because our study was retrospective, we must assume that this ethical concern was not an issue.
Our study found that propofol did not shorten seizure duration. Although anesthesia with propofol has been associated with shorter ECT seizures, other anesthetic agents used for comparison with the propofol may have affected earlier results. Our study suggests the importance of the control group who received ECTs without anesthesia for comparing the effects of anesthetic agents on seizure duration: results that are more reliable could be obtained and controversial conclusions minimized.
Okan Caliyurt, MD Erdal Vardar, MD Cengiz Tuglu, MD Ercan Abay, MD Edirne, Turkey
Deliberate Ingestion of Peanut as a Suicide Attempt
Dear Editor: I report the case of a man, aged 24 years, with an established history of severe anaphylaxis to peanuts, who deliberately ingested peanut butter as a suicide attempt while admitted to hospital.
The patient was admitted to the psychiatry service for severe depression but had not revealed overt suicidal ideation. His medical history was significant for severe anaphylactic reactivity to peanuts. During his admission, he prepared himself a sandwich that he later admitted was intentionally contaminated with peanut butter. Within 5 minutes of consuming the sandwich, he developed shortness of breath and swelling of the lips and throat, followed by an erythematous, pruritic rash involving his entire body. He was admitted to the emergency department, where he was noted to be tachycardic and hypoxic, with an oxygen saturation of 91% on room air. Immediate treatment included subcutaneous epinephrine 0.3 cc at 1:1000 dilution, intravenous diphenhydramine 50 mg, and intravenous solumedrol 125 mg. His symptoms resolved within 30 minutes, after which he was observed for another 3 1/2 hours.
Later, he acknowledged that the peanut butter ingestion was a deliberate suicide attempt. He was subsequently placed on a suicide watch and denied access to all peanutcontaining products.
While there are rare reports of patients with asthma who use their disease as a modality for suicide (either through deliberate avoidance of medications or deliberate induction of a severe attack) (1), no cases are thus far reported of deliberate induction of anaphylactic reactivity. This is the first reported case of a patient exploiting allergic sensitivity in this manner, demonstrating a possible avenue of suicidal attempt. Upon admission to a psychiatric ward, food allergies should be welldocumented; foods with anaphylactic potential should not be accessible to patients.
Note
An abstract of this case was previously presented at the Canadian Society of Allergy and Clinical Immunologoy Meeting; 2002; Quebec (QC).
